/
BIOX
$0.33-$0.00 (-0.66%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$21.4M
64M shares
52-week range
$0.31 – $5.00
0% from low
Exchange
NASDAQ
CS
Price (6 mo)
Loading chart…
Change$-13.67
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $133.5M | $160.3M | $172.4M | $206.7M | $328.5M | $419.4M | $464.8M | $333.3M |
| Cost of revenue | $77.1M | $86.7M | $92.9M | $115.8M | $202.0M | $239.2M | $283.2M | $205.2M |
| Gross profit | $56.4M | $73.6M | $79.5M | $90.9M | $126.4M | $180.2M | $181.6M | $128.2M |
| Gross margin | 42.2% | 45.9% | 46.1% | 44.0% | 38.5% | 43.0% | 39.1% | 38.4% |
| R&D | $4.0M | $3.7M | $4.2M | $5.6M | $6.9M | $15.3M | $17.2M | $14.9M |
| Operating income | $15.7M | $32.1M | $39.1M | $38.4M | $39.9M | $54.2M | $44.8M | −$761.9K |
| EBITDA | −$12.8K | $17.3M | $30.6M | $43.7M | $47.9M | $72.4M | $55.5M | −$9.8M |
| Net income | −$11.0M | −$18.4M | $3.4M | −$6.9M | −$7.2M | $18.8M | $3.2M | −$55.4M |
| Net margin | -8.3% | -11.5% | 1.9% | -3.3% | -2.2% | 4.5% | 0.7% | -16.6% |
| EPS (diluted) | -0.39 | -0.60 | 0.09 | -0.18 | -0.17 | 0.30 | 0.05 | -0.82 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $307M | $-0.16 | $-0.16–$-0.16 | 1 |
| 2027 | $379M | $0.05 | $0.05–$0.05 | 1 |
| 2028 | $511M | $0.56 | $0.56–$0.56 | 1 |
| 2029 | $579M | $0.82 | $0.82–$0.82 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Bioceres Crop Solutions Corp. Ordinary Shares
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
www.biocerescrops.com- Employees
- 751
- IPO / List date
- Mar 22, 2018
Held by traders on TradeandTell
No one on the platform currently holds BIOX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BIOX as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BIOX yet.
